Atlas Trials

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

Clinical trial NCT00139971 · UNKNOWN

Trial details

NCT number
NCT00139971
Sponsor
West Japan Thoracic Oncology Group
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2001-12-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.